ストックスクリーナーアプリを入手
36.56
0.01%
0.07
前日終値:
$36.63
開ける：
$36.5
24時間の取引高:
103.89K
Relative Volume:
0.03
時価総額：
$15.82B
収益：
$2.31B
当期純損益:
$1.66B
株価収益率:
15.90
EPS:
2.3
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
+1.76%
1か月 パフォーマンス:
+1.09%
6か月 パフォーマンス:
+13.80%
1年 パフォーマンス:
+32.01%
1日の値動き範囲:
$36.50
$36.74
1週間の範囲:
$35.79
$37.13
52週間の値動き範囲:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
36.59 | 15.83B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.68 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
478.99 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
574.35 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
841.11 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.57 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update - MarketBeat
Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Why Royalty Pharma plc (RPD) stock could outperform next yearEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
What the charts say about Royalty Pharma plc todayJuly 2025 Breakouts & Verified Entry Point Signals - newser.com
Is Royalty Pharma plc (RPD) stock a buy during volatile markets2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Detecting support and resistance levels for Royalty Pharma plcEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
Is Royalty Pharma plc (RPD) stock undervalued historicallyWeekly Trading Summary & Verified Technical Trade Signals - nchmf.gov.vn
Is Royalty Pharma plc reversing from oversold territoryMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Using Python tools to backtest Royalty Pharma plc strategiesWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
What candlestick patterns are forming on Royalty Pharma plcWeekly Gains Report & Smart Money Movement Tracker - newser.com
Does Royalty Pharma plc qualify in momentum factor screening2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
What indicators show strength in Royalty Pharma plcQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Price-Driven Insight from (RPRX) for Rule-Based Strategy - news.stocktradersdaily.com
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - sharewise.com
Nordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Why retail investors pile into Royalty Pharma plc stockMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22 - MarketBeat
Is Royalty Pharma plc (RPD) stock bottoming after sell offEarnings Risk Summary & Stepwise Swing Trade Plans - nchmf.gov.vn
How strong is Royalty Pharma plc stock revenue growth2025 Key Lessons & Proven Capital Preservation Tips - nchmf.gov.vn
Market Moves: How strong is Royalty Pharma plc stock revenue growthTake Profit & Precise Buy Zone Identification - nchmf.gov.vn
Will Royalty Pharma plc stock benefit from upcoming earnings reports2025 EndofYear Setup & Consistent Return Strategy Ideas - nchmf.gov.vn
Trading Recap: Is Royalty Pharma plc (RPD) stock positioned for secular growth2025 Technical Overview & Fast Exit and Entry Strategy Plans - nchmf.gov.vn
Why Royalty Pharma plc stock is a must watch in 2025July 2025 Rallies & Stock Market Timing Techniques - nchmf.gov.vn
Royalty Pharma Keeps Quarterly Dividend at $0.22 a Share, Payable Dec. 10 to Holders of Record on Nov. 14 - MarketScreener
Royalty Pharma plc Approves Dividend on Class A Ordinary Share for Fourth Quarter of 2025 , Payable on December 10, 2025 - MarketScreener
Royalty Pharma plc Announces Fourth Quarter 2025 Dividend of $0.22 per Class A Ordinary Share - Quiver Quantitative
Royalty Pharma Declares Fourth Quarter 2025 Dividend - Bluefield Daily Telegraph
$0.22 Q4 2025 Dividend: Royalty Pharma Declares Payment Dec 10, Record Date Nov 14, 2025 - Stock Titan
Aberdeen Group plc Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
S Bank Fund Management Ltd Buys Shares of 43,508 Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc RPD a good long term investmentEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in
What’s the recovery path for long term holders of Royalty Pharma plcMarket Risk Analysis & Safe Capital Growth Trade Ideas - newser.com
Morningstar Investment Management LLC Acquires Shares of 8,307 Royalty Pharma PLC $RPRX - MarketBeat
Callan Family Office LLC Buys Shares of 16,418 Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Valuation: Is There More Upside After This Year’s 40% Rally? - Yahoo Finance
Royalty pharma projects 6-12% growth in 2025 portfolio receipts with $2B share buyback plan - MSN
3 Healthcare Stocks We Keep Off Our Radar - The Globe and Mail
Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 23.59% Upside Potential in the Biotech Royalty Space - DirectorsTalk Interviews
Is this a good reentry point in Royalty Pharma plcQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
Royalty Pharma PLC $RPRX Shares Sold by Board of the Pension Protection Fund - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
2.21%
大文字化:
|
ボリューム (24 時間):